KDM2A and urinary bladder cancer: Additionally, we analyzed TCGA bladder cancer datasets and found that the proportion of KDM2A amplification and gain alteration in high-grade bladder cancer was significantly higher than that in low-grade bladder cancer (Fig. 1E).